
Anakinra injection
Form: Injection(SQ)
Strength: 100 mg/mL
Reference Brands: Kinerso, Kineret(US)
Category: Immune Disorder
Anakinra prefilled pens, marketed as Kineret, are approved in both the US by the FDA and in the EU via EMA for rheumatoid arthritis, Still's disease, and autoinflammatory conditions. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety, manufacturing quality, and pharmacovigilance data. In the US, the FDA reviews detailed clinical trial and manufacturing information, while the EMA ensures compliance with regional standards. For guidance on dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring compliance is essential for timely approval, supporting safe and effective treatment options for autoimmune and autoinflammatory diseases worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Belimumab prefilled syringe
Strength: 200 mg/ten 1 mL for SQ; 10 mg/mL for IV
Form: Subcutaneous (SC) and intravenous (IV) Prefilled syringe
Reference Brands: Benlysta(US & EU)
View Details Get EnquiryIVIG (Intravenous Immunoglobulin) solution
Strength: 5% or 10%
Form: Intravenous infusion
Reference Brands: Gammagard (Gamunex-C, Flebogamma),Privigen, Octagam, Gamunex-C(US)
View Details Get EnquiryUstekinumab Injection
Strength: SQ:: 45 mg, 90 mg; IV: 130 mg/vial
Form: SQ and IV injection
Reference Brands: Stelara(US)
View Details Get EnquiryEverolimus tablets
Strength: 0.75 mg, 1.25 mg, 2.5 mg, 5 mg, 7.5 mg, 10 mg
Form: Tablet
Reference Brands: Zortress, Afinitor(US & EU)
View Details Get Enquiry